Financials
- Market Capitalization 2.1 B
- Employee 361
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-10.87
売上高対価格比率
7 992.14
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1887 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.58 USD | -0.42% | +4.94% | +2.73% | +38.98% | 2.21 B USD | ||
| 1893 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.44 USD | -1.29% | +5.76% | +3.30% | +16.74% | 2.16 B USD | ||
| 1916 | VRDN Viridian Therapeutics, Inc. - Common Stock | 19.07 USD | +2.20% | +0.26% | -11.18% | -15.06% | 2.16 B USD | ||
| 1920 | NVAX Novavax, Inc. - Common Stock | 12.72 USD | -0.24% | +21.37% | +35.03% | +51.07% | 2.10 B USD |